Certain Standard Cell Libraries, Products Containing or Made Using the Same, Integrated Circuits Made Using the Same, and Products Containing Such Integrated Circuits; Institution of Investigation Pursuant to 19 U.S.C. 1337, 4757 [2014-01704]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 19 / Wednesday, January 29, 2014 / Notices
identified for sale. However, land use
applications may be considered after the
sale if the parcel is not sold. The parcel
may be subject to land use applications
received prior to publication of this
Notice if processing the application
would have no adverse effect on the
marketability of title, or the FMV of the
parcel. Information concerning the sale,
encumbrances of record, appraisals,
reservations, procedures and conditions,
CERCLA, and other environmental
documents that may appear in the BLM
public files for the proposed sale parcels
are available for review during business
hours, 7:30 a.m. to 4:30 p.m. Pacific
Time, Monday through Friday, at the
BLM Las Vegas Field Office, except
during Federal holidays.
In order to determine the FMV
through appraisal, certain extraordinary
assumptions and hypothetical
conditions may have been made
concerning the attributes and
limitations of the lands and potential
effects of local regulations and policies
on potential future land uses. Through
publication of this Notice, the BLM
advises that these assumptions may not
be endorsed or approved by units of
local government.
It is the buyer’s responsibility to be
aware of all applicable Federal, State,
and local government laws, regulations
and policies that may affect the subject
lands, including any required
dedication of lands for public uses. It is
also the buyer’s responsibility to be
aware of existing or prospective uses of
nearby properties. When conveyed out
of Federal ownership, the lands will be
subject to any applicable laws,
regulations, and policies of the
applicable local government for
proposed future uses. It is the
responsibility of the purchaser to be
aware through due diligence of those
laws, regulations, and policies, and to
seek any required local approvals for
future uses. Buyers should also make
themselves aware of any Federal or
State law or regulation that may impact
the future use of the property. Any land
lacking access from a public road or
highway will be conveyed as such, and
future access acquisition will be the
responsibility of the buyer.
Any comments regarding the
proposed sale will be reviewed by the
BLM Nevada State Director or other
authorized official of the Department of
the Interior, who may sustain, vacate, or
modify this realty action in response to
such comments. In the absence of any
comments, this realty action will
become the final determination of the
Department of the Interior.
VerDate Mar<15>2010
16:05 Jan 28, 2014
Jkt 232001
Authority: 43 CFR 2711.1–2.
Catrina Williams,
Assistant Field Manager, Division of Lands.
[FR Doc. 2014–01759 Filed 1–28–14; 8:45 am]
BILLING CODE 4310–HC–P
INTERNATIONAL TRADE
COMMISSION
[Corrected; Inv. No. 337–TA–906]
4757
5. Outstanding action jackets: none.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission:
Issued: January 23, 2014.
William R. Bishop,
Supervisory Hearings and Information
Officer.
Certain Standard Cell Libraries,
Products Containing or Made Using
the Same, Integrated Circuits Made
Using the Same, and Products
Containing Such Integrated Circuits;
Institution of Investigation Pursuant to
19 U.S.C. 1337
[FR Doc. 2014–01819 Filed 1–27–14; 11:15 am]
U.S. International Trade
Commission
ACTION: Correction of Institution of
investigation pursuant to 19 U.S.C.
1337.
Manufacturer of Controlled
Substances; Notice of Registration;
Irix Manufacturing, Inc.
AGENCY:
Correction is made to the
Scope of Investigation section. The date
the Commission ordered action under
the scope should be corrected from
January 7, 2014 to January 17, 2014.
SUMMARY:
By order of the Commission.
Issued: January 24, 2014.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2014–01704 Filed 1–28–14; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–14–002]
Sunshine Act Meetings
United
States International Trade Commission.
TIME AND DATE: January 31, 2014 at 11
a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: none
2. Minutes
3. Ratification List
4. Vote in Inv. Nos. 701–TA–510 and
731–TA–1245 (Preliminary)
(Calcium Hypochlorite from China).
The Commission is currently
scheduled to complete and file its
determinations on February 3, 2014;
views of the Commission are
currently scheduled to be
completed and filed on February
10, 2014.
AGENCY HOLDING THE MEETING:
PO 00000
Frm 00103
Fmt 4703
Sfmt 9990
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
By Notice dated August 5, 2013, and
published in the Federal Register on
August 14, 2013, 78 FR 49546, IRIX
Manufacturing, Inc., 309 Delaware
Street, Greenville, South Carolina
29605, made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Noroxymorphone (9668), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
the listed controlled substance as API
for clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of IRIX
Manufacturing, Inc., to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated IRIX
Manufacturing, Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: January 15, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–01781 Filed 1–28–14; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 79, Number 19 (Wednesday, January 29, 2014)]
[Notices]
[Page 4757]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01704]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Corrected; Inv. No. 337-TA-906]
Certain Standard Cell Libraries, Products Containing or Made
Using the Same, Integrated Circuits Made Using the Same, and Products
Containing Such Integrated Circuits; Institution of Investigation
Pursuant to 19 U.S.C. 1337
AGENCY: U.S. International Trade Commission
ACTION: Correction of Institution of investigation pursuant to 19
U.S.C. 1337.
-----------------------------------------------------------------------
SUMMARY: Correction is made to the Scope of Investigation section. The
date the Commission ordered action under the scope should be corrected
from January 7, 2014 to January 17, 2014.
By order of the Commission.
Issued: January 24, 2014.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2014-01704 Filed 1-28-14; 8:45 am]
BILLING CODE 7020-02-P
